On Monday, SeaStar Medical Holding Corp (NASDAQ: ICU) opened higher 11.14% from the last session, before settling in for the closing price of $0.8. Price fluctuations for ICU have ranged from $0.31 to $6.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 88.39% at the time writing. With a float of $26.61 million, this company’s outstanding shares have now reached $27.91 million.
Let’s look at the performance matrix of the company that is accounted for 19 employees.
SeaStar Medical Holding Corp (ICU) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SeaStar Medical Holding Corp is 4.66%, while institutional ownership is 6.98%. The most recent insider transaction that took place on Aug 22 ’25, was worth 8,000. In this transaction Chief Medical Officer of this company bought 10,000 shares at a rate of $0.80, taking the stock ownership to the 58,184 shares. Before that another transaction happened on Jun 30 ’25, when Company’s Director bought 10,000 for $0.42, making the entire transaction worth $4,174. This insider now owns 28,000 shares in total.
SeaStar Medical Holding Corp (ICU) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.39% per share during the next fiscal year.
SeaStar Medical Holding Corp (NASDAQ: ICU) Trading Performance Indicators
Check out the current performance indicators for SeaStar Medical Holding Corp (ICU). In the past quarter, the stock posted a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.45, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of SeaStar Medical Holding Corp (ICU)
SeaStar Medical Holding Corp (NASDAQ: ICU) saw its 5-day average volume 1.02 million, a negative change from its year-to-date volume of 3.19 million. As of the previous 9 days, the stock’s Stochastic %D was 63.64%.
During the past 100 days, SeaStar Medical Holding Corp’s (ICU) raw stochastic average was set at 50.12%, which indicates a significant decrease from 83.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0737 in the past 14 days, which was lower than the 0.0962 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6965, while its 200-day Moving Average is $1.4958. Nevertheless, the first resistance level for the watch stands at $0.9357 in the near term. At $0.9823, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0596. If the price goes on to break the first support level at $0.8118, it is likely to go to the next support level at $0.7345. Assuming the price breaks the second support level, the third support level stands at $0.6879.
SeaStar Medical Holding Corp (NASDAQ: ICU) Key Stats
There are currently 27,915K shares outstanding in the company with a market cap of 24.81 million. Presently, the company’s annual sales total 140 K according to its annual income of -24,830 K. Last quarter, the company’s sales amounted to 340 K and its income totaled -2,000 K.
